We have significant experience in immune directed therapies

We have the longest tenure in the industry with multiple years of assisting successful Cell & Gene Therapy (CGT) product launches. Our experience and regulatory knowledge will deliver critical data helping you successfully move your product from preclinical development through your manufacturing needs. In addition, we provide a complete analytical workflow that provides key insights to complex clinical questions. Our analytical tools and best practices ensure the most efficient clinical development timelines without sacrificing quality standards.

Our extensive experience in immune directed therapies includes CAR-T or TCR, gene therapies, iRNA therapies, bi/tri-specific antibodies and selective kinase inhibitors.